SUMMARY Using a radioimmunoassay technique serum alpha-fetoprotein could be detected in healthy adults in concentrations of less than 20 ,ug/l.
Alpha-fetoprotein is an alpha globulin produced by the fetal liver which disappears from the serum within three weeks of birth. Tatarinov (1964) described the association of primary liver cell carcinoma with the appearance of alpha-fetoprotein in the serum, and this finding has been confirmed by others (Abelev, 1968; Alpert et al., 1968;  Smith and Todd, 1968; Foli et al., 1969; Kew, 1974) . The original method of detection was the relatively insensitive technique, gel diffusion. More recently, radioimmunoassay techniques have shown that alphafetoprotein can be detected in healthy adults in concentrations of less than 20 ,ug/l (Purves and Purves, 1972; Adinolfi et al., 1975) . Using this highly sensitive method, patients with acute and chronic liver disease have also shown increased values (Smith, 1971; Akeyama et al., 1972; Kew et al., 1973; Silver et al., 1974; Bloomer et al., 1975) . It has been suggested that liver cell regeneration may be responsible for the rises in serum alpha-fetoprotein in these patients with non-malignant liver disease (Silver et al., 1974; Bloomer et al., 1975) .
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Received for publication 17 February 1977 We have carried out serial serum alpha-fetoprotein determinations in subjects with acute hepatic damage in order to assess the value of this test as a marker of hepatocellular regeneration. Subjects with chronic liver disease were also examined, in particular to determine whether this highly sensitive method of alpha-fetoprotein determination was of value in predicting the development of primary liver cell carcinoma.
Patients studied
Control sera came from 50 healthy members of the hospital staff.
The patients with acute liver disease suffered from acute, non-fulminant viral hepatitis (44), paracetamol overdose (eight, of whom three received cysteamine), and fulminant hepatitis (six, five presumed viral and one halothane-related); serial blood samples were taken, usually every two to four days.
One hundred and sixty-three patients with biopsyproven chronic liver disease were studied. They comprised primary biliary cirrhosis (47), cryptogenic cirrhosis (16), alcohol-related liver disease (44), and chronic active liver disease either of the 'lupoid' variety or associated with serum hepatitis B surface antigen (HBsAg) (56) . 704
Methods
All sera were tested for the presence of alphafetoprotein using the standard counter-immunoelectrophoresis (CIEP) technique employing commercial alpha-fetoprotein antibody. Serum concentrations of <500 ,ug/l were not detected by this method.
The Abbott radioimmunoassay kit employs the double antibody technique and was used on all the sera, the procedure being carried out according to the manufacturer's instructions. This method detected serum alpha-fetoprotein levels of 5 to 320 ,ug/l. When levels of alpha-fetoprotein greater than 320 ,ug/l were detected, the test was repeated after the sera had been diluted with normal saline to 1:100 or more.
All sera were also tested for the presence of hepatitis B surface antigen (HBsAg) using the direct haemagglutination test (Burroughs WelcomeHepatest).
Serum aspartate transaminase activity was determined on all sera.
Results

HEALTHY ADULTS
The serum specimens obtained from 50 healthy adults all had alpha-fetoprotein concentrations of < 20 ,ug/l and were negative by CIEP. The mean duration of symptoms before admission to hospital was comparable in the two groups, namely, 9*4 days in those with raised alphafetoprotein levels and 117 days in those whose serum alpha-fetoprotein remained within the normal range. Similarly, the average hospital stay was comparable 20 and 17 days respectively (Fig. 1 ).
PARACETAMOL POISONING
Five of the eight patients, two of whom had been give cysteamine, developed a raised serum alphafetoprotein. In these five the peak serum alphafetoprotein level ranged from 40 to 450 ,ug/l and was seen 2-10 days after paracetamol ingestion. In three of the five the highest serum alpha-fetoprotein values were noted at 7-10 days, being their last day in hospital. In the other two (both of whom had been given cysteamine) the serum alpha-fetoprotein peak occurred two days after ingestion and the levels were seen to fall to normal by the time of discharge. All but one of these subjects showed a rise in serum aspartate transaminase activity (Table 1) .
FULMINANT HEPATITIS All six cases of fulminant viral hepatitis died within seven days of admission. In three, serum alphafetoprotein levels remained within normal limits until death at two, three and seven days. Serum alpha-fetoprotein values were above normal in the three other cases, the peak range being 50-112 ,ug/l (Table 2 ). In two, the levels fell but did not reach normal values before death. The average duration group.bmj.com on August 28, 2017 -Published by http://jcp.bmj.com/ Downloaded from found between aspartate transaminase level and serum alpha-fetoprotein (r = 0 09). In none of these sera could alpha-fetoprotein be detected using the CIEP test. Alpha-fetoprotein could be detected by both CIEP and radioimmunoassay in six later sera obtained from two of the four subjects who developed a primary liver cell carcinoma during the survey.
Discussion
Using radioimmunoassay, we have confirmed that alpha-fetoprotein can be detected in the serum of normal, healthy adults in concentrations of less than 20 ,ug/l. Serum concentrations greater than this but less than 500 ,Lg/l were detected in patients with nonmalignant acute and chronic liver disease. The lower limit of sensitivity of the standard CIEP test for detecting serum alpha-fetoprotein seems to be 500 ,ug/l, and this test became positive only in patients who developed primary liver cell carcinoma.
Patients with acute, non-fulminant viral hepatitis, both type B and non B studied serially, showed a rise above normal of serum alpha-fetoprotein. This transient rise occurred once the serum transaminase levels started to fall, the serum alpha-fetoprotein levels returning to normal by the time of discharge from hospital. Serum studies made before and after partial hepatectomy experiments in animals have indicated that hepatocyte proliferation is related to alpha-fetoprotein production (Sell et al., 1974) . It seems likely that the increased serum alpha-fetoprotein concentrations found a week or more after the onset of an acute hepatitis also reflect hepatic regeneration. However, in about half the subjects studied, the serum alpha-fetoprotein did not rise. The mean duration of illness before admission was about the same as in those with an increased serum alpha-fetoprotein. It is therefore unlikely that any transient rise was missed. The peak serum transaminase activity in those with normal serum alphafetoprotein levels tended to be lower than in those exhibiting an increase; it is possible that the smaller degree of liver cell necrosis was followed by less liver cell regeneration, which may explain the absence of an increase in alpha-fetoprotein concentration.
The observations in the paracetamol group suggest a correlation between degree of liver cell necrosis as judged by serum transaminase measurements and subsequent alpha-fetoprotein production. In these patients a rise in serum alpha-fetoprotein was recorded within 48 hours of ingestion of the drug, much sooner than in viral hepatitis. This may reflect the faster evolution of hepatic damage after paracetamol ingestion than after viral hepatitis. Patients given cysteamine within a few hours of paracetamol ingestion are protected from some of the hepatotoxic activity of the drug (Prescott et al., 1974) , and in general this was reflected in our study by lower aspartate transaminase and also alpha-fetoprotein levels. Nevertheless two patients given cysteamine did have a small increase in alpha-fetoprotein in spite of normal or only slightly increased transaminase levels. In these cases it is probable that some hepatic necrosis occurred but was not reflected in the standard liver function tests. These data are also consistent with the hypothesis that the rise in alphafetoprotein is due to increased synthesis of the protein by regenerating hepatocytes.
Half the patients with fatal fulminant hepatitis developed raised serum alpha-fetoprotein levels. The duration of symptoms before admission was much greater in those patients than in those whose serum alpha-fetoprotein levels remained within normal limits. A raised serum alpha-fetoprotein during the course of fulminant hepatitis has been said to be a favourable prognostic sign (Karvountzis and Redeker, 1974) . Our findings are more in agreement with those of Bloomer et al. (1975) and suggest that the increase in serum alpha-fetoprotein in fulminant hepatitis is related to the duration of illness regardless of the final outcome.
Raised levels of serum alpha-fetoprotein greater than 20 ,tg/l but generally less than 500 ,ug/l were seen in a wide variety of chronic liver disease. These rises were often transient. No correlation existed between serum transaminase activity and alphafetoprotein measured at the same time. It seems probable that these fluctuating changes are a reflection of synthesis by regenerating hepatocytes, although direct proof of this is still lacking. Steadily increasing levels are highly suspicious of the development of primary liver cell carcinoma. 
